Calidi Biotherapeutics, Inc. — Institutional Ownership
Which tracked institutions hold CLDI, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
4
Funds holding
$7391
Total value held
Buying
3 added/new · 0 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Northern Trust Corp | $3019 | 17758 | — | Held |
| 2 | Morgan Stanley | $2251 | 13244 | +3777 | +39.90% |
| 3 | Ubs Group Ag | $1340 | 7882 | +7882 | NEW BUY |
| 4 | Citigroup Inc | $781 | 4594 | +4593 | +459300.00% |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.